Bellevue Group Ag Relmada Therapeutics, Inc. Transaction History

Bellevue Group Ag

  • $5.02 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$18.3 - $37.02 $332,822 - $673,282
18,187 Added 51.96%
53,187 $1.97 Million
Q2 2022

Aug 11, 2022
BUY
$16.5 - $30.34 $313,500 - $576,460
19,000 Added 118.75%
35,000 $665,000
Q1 2022

May 13, 2022
BUY
$16.72 - $26.99 $267,520 - $431,840
16,000 New
16,000 $432,000

About RELMADA THERAPEUTICS, INC.

RLMD Quotes by TradingView
  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $8.01M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email